Tech Company Financing Transactions
Pinpoint Therapeutics Funding Round
Pinpoint Therapeutics, operating out of Philadelphia, received $1 million from Kairos Ventures and private investors.
Transaction Overview
Company Name
Announced On
2/13/2020
Transaction Type
Debt
Amount
$1,000,000
Round
Seed
Investors
Kairos Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3401 Grays Ferry Ave. Bldg 176 1032
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Undisclosed
Website
Email Address
Overview
Pinpoint Therapeutics is developing novel cancer treatment options aimed to specifically inhibit autophagy, a key cell survival and treatment resistance pathway in cancer. Pinpoint inhibitors target a recently discovered enzyme in the autophagy pathway called PPT1, which is highly expressed across most cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christian Peters
Co-Founder
Ravi Amaravadi
Co-Founder
Jeffrey Winkler
Browse more venture capital transactions:
Prev: 2/13/2020: NewSpace Networks venture capital transaction
Next: 2/13/2020: Merryfield venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs